Hot line:010-83057670
ENCustomized development of high-end raw materials and excipients in short supply in China, and development of slow and controlled release preparations based on hot melt extrusion, spray drying and other technologies.
About
About Us
Stock(600222)
Leadingpharm (stock code 600222) was established in 2005 and is a high-quality supplier providing full industry chain services such as pharmaceutical CMC, clinical CRO, and MAH to the world. The company has a senior R&D management team of over a thousand people, a comprehensive drug R&D quality management system, and rich project experience, providing customers with customized solutions throughout the entire process from product approval to commercial transformation.
Service
Services
Solution
Dedicated to providing customers with integrated solutions for pharmaceutical R&D, clinical research and MAH
-
API and Excipients R&D
Synthesis and Development of Raw and Auxiliary Materials， Research on the Substitution of High-end Auxiliary Materials
-
Preparation R&D
Formulation and Process Development of Generic Drugs, Improved New Drugs and Innovative Drugs
-
Analytical Test
Drug Quality Research，Special Substance Test，Research on Compatibility of Drug Contact System，Analysis of complex formulation excipients，Other Tests
-
IVIVR
Predicting of PK Curve and Pesticide Effect，Guidance for Clinical Trial Design，Establishment of IVIVR Models，Data Support for Bioequivalence Exemption
-
Clinical CRO
Phase I-IV clinical trial, PK/PD, IIT, medical service, third-party audit
-
MAH Services
Project Establishment Service, Pharmaceutical Administration Service, Quality Management System Service
-
Registration and Filing
Regulatory?submissions? in?China?and?the?US, ?compliance?consulting, communications?with ?the?Center?for?Drug?Evaluation?(CDE).
-
Other services
Park Services, Financial Services
- Shenyang
- Dalian
- Hangzhou
- Beijing
- Shijiazhuang
- Zhengzhou
- Wuhan
- Changsha
- Guangzhou
- Taiyuan
- Lanzhou
- Xian
- Tianjin
-
Zhengzhou Liquid Formulation Consistency Evaluation Center
A 4000㎡ R&D laboratory has been established in Lifezhengzhou Biopharmaceutical Park to conduct consistency evaluation of liquid preparations in batches -
Beijing Operations Management Center & Pharmaceutical Research Institute
1、The headquarters of Leadingpharm (Operations Management Center):
The company's headquarters is located in the Software Park of Beijing Zhongguancun Science Park. As the company's intelligent hub and core engine, it gathers many domestic and foreign experts to jointly build accurate project plans and ensure the stable and efficient operation of projects in various regions.
2、Beijing Pharmaceutical Research Institute:Beijing Pharmaceutical Research Institute is located in Zhongguancun High-tech Park, with a research and development laboratory of 10000㎡, covering various links such as product project approval, raw material drug trial, formulation research and development, analytical testing, and pharmaceutical registration.
-
Chongqing High end Preparation Research Institute
-
Hangzhou High-end Pediatric Medicine Research Institute
Focuses on customized development of children's granules (sustained-release, enteric coated granules, direct swallowing granules, traditional Chinese medicine granules), oral films, inhalation preparations, transdermal preparations, and dietary supplements.
NEWS
News
- Company News
-
In-depth Interview | The "Deep Blue Ocean" Force in the CRO Field of Cell and Gene Therapy (CGT)
2025-09-15 -
Pooling Strengths of Industry-Academia-Research-Application, Promoting Development Driven by Innovation | The 5th Four-Party Party Building Event & Commemoration of the 80th Anniversary of the Victory of the Anti-Japanese War Successfully Held
2025-08-11 -
World's First! Leadingpharm CXO · Deep Blue Ocean Bio-Pharmaceutical Assists Clinical Research of Non-Viral Vector Gene Therapy for DMD, Opening a New Paradigm in Gene Therapy!
2025-07-15
010-83057670
Address：
Marketing Department：
Leadingpharm
Pharm News
010-61006450
